Efficacy and Safety of Vildagliptin as an Add-on to Insulin with or without Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A 12-week, Double-Blind, Randomized Study.

Hirose, Takahisa; Suzuki, Manabu; Tsumiyama, Isao

Hirose, Takahisa; Suzuki, Manabu; Tsumiyama, Isao.

Afiliação

Hirose T; Division of Diabetes, Metabolism and Endocrinology, Department of Medicine, Toho University School of Medicine, Tokyo, Japan. takahisa.hirose@med.toho-u.ac.jp.
Suzuki M; Development Division, Clinical Development, Cardio-Metabolic Clinical Franchise Department, Novartis Pharma KK, Tokyo, Japan.
Tsumiyama I; Development Division, Clinical Development, Biometrics and Statistical Sciences Department, Novartis Pharma KK, Tokyo, Japan.

Diabetes Ther ; 6(4): 559-571, 2015 Dec.

Article em En | MEDLINE | ID: mdl-26620049

Palavras-chave

Hypoglycemia; Insulin; Japanese; Type 2 diabetes mellitus; Vildagliptin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Diabetes Ther Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google